期刊文献+

MMP9-PEX的原核表达、纯化与复性研究 被引量:1

Prokaryotic Expression and Purification and Renaturation of MMP9-PEX
原文传递
导出
摘要 目的 对人基质蛋白酶9(matrix metalloproteinase,MMP9)C端血红素结合蛋白样结构域(hemopexin domain,PEX)的原核表达条件、透析复性条件进行优化,以获得高表达的活性蛋白.方法 将构建好的原核表达载体PET-his-MMP9-PEX转化至大肠埃希菌菌株BL21(DE-3),异丙基β-D硫代半乳糖苷(IPTG)诱导后产生包涵体蛋白,探讨不同IPTG浓度、不同诱导时间、不同菌液密度值对目的 蛋白表达产量的影响;盐酸胍裂解包涵体,采用NI-NTA进行纯化,对纯化蛋白的透析复性条件进行优化;采用明胶酶谱的方法检测MMP9-PEX的活性.结果 经纯化透析复性后蛋白的纯度在95%以上,复性回收率为36.86%.结论 本研究优化了MMP9-PEX的原核表达、透析复性条件,获得了有活性的MMP9-PEX蛋白,为进一步研究MMP9-PEX的功能提供了实验基础. Objective To optimize conditions for prokaryotic expression, purification and renaturation of human carboxyl-terminal hemopexin domain (PEX) of matrix metalloproteinase (MMP9) . Methods The expression vector, PET-his-MMP9-PEX, was transformed into E. coli BI21 (DE3) under IPTG induction. Expression level of PEX was examined in various culture conditions, including IPTG concentration, induced time, OD values of bacilli-solution and renatured conditions with various dialysis. Cytoplasmic inclusions were cleaved by guanidine hydroehloride. The recombinant protein was purified by affinity chromatography. Enzymatic activity of MMP-9-PEX was detected by gelatin zymography. Results The purity of renatured MMP-9-PEX protein was a- bove 95% , with36. 86% of renaturation rate. Conclusion The conditions for prokaryotic expression, purification and renaturation of functional human MMPg-PEX were optimized, providing experimental basis for further study of MMP9-PEX function.
出处 《医学分子生物学杂志》 CAS CSCD 2010年第6期504-507,512,共5页 Journal of Medical Molecular Biology
基金 国家自然科学基金(No.30672771)
关键词 血红素蛋白样结构域 原核表达 纯化 复性 hemopexin domain prokaryotic expression purification renaturation
  • 相关文献

参考文献10

  • 1ABDALLAH M A,NAKAJIMA S T,LIN P C,et al. Plasma matrix metalloproteinase activity during the menstrual cycle of healthy ovulatory patients who underwent tubal ligation [ J ]. Fertil Steril, 2006,84(6) :1766-1767.
  • 2XUE M, JACKSON C J. Targeting matrix metallopro-teases to im- prove cutaneous wound healing [ J ]. Expert Opin Ther Targets, 2007 ,10( 1 ) :143-155.
  • 3DAS S K, YANO S, WANG J,et al. Expression of matrix metallo- proteinase and tissue inhibitiors of metalloproteinase in the uterus during the peri-implantation period[ J]. Dev Genet, 1997,21 ( 1 ) : 44-45.
  • 4TAMAHASH1 U, KUMAGAI J,TAKIZAWA T, et al. Expression a- nd intracellular localization of matrix metalloproteinases in intra- ductal papillarymucinous neoplasms of the pancreas [ J ]. Virchows Arch ,2008,453 ( 1 ) :79-87.
  • 5HONG C S, FELLOWS W, NIRANJAN A, et al. Ectopic matrix metalloproteinase-9 expression in human brain tumoreells enhances oncolytic HSV vector infection [ J]. Gene Ther,2010,28 ( 6 ) :42- 46.
  • 6吴丰华,张桂梅,刘毅,耿辉,李东,袁野,肖晗,冯作化.重组纤维连接蛋白多肽CH50对黑色素瘤B16细胞侵袭能力的抑制作用及机制[J].医学分子生物学杂志,2006,3(3):170-175. 被引量:6
  • 7BRUNO C M, VALENTI M, BERTINO G, et al. Altered pattern of circulating matrix metalloproteinases 2and 9 tissue inhibitor of met- alloproteinase 2 in patients with HCV-related chtonichepatitis [ J]. Panminerva Med ,2009,51 ( 4 ) : 19-26.
  • 8RODERFOLD M, SULEJCZAK D. MMP-9-hemopexin domain ha-topers adhesion and migration of colorectal cancer cells [ J ]. Med Sci,2007,30(4) :92-101.
  • 9WALSKI M,MADEJSKA G. MMP2 and MMP9 in Immature endo- thelial cells following surgical injury of rat cerebral cortexa prelimi- nary study [ J ]. Folia Neuropathol, 2009,47 ( 4 ) : 338-346.
  • 10SINGH S M,PANDA A K. Solubilization and refolding of bacterial inclusion body proteins [ J ]. Biosci Bioeng, 2005,99 ( 4 ) :303-310.

二级参考文献3

共引文献5

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部